id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2006-E-0439-0010,FDA,FDA-2006-E-0439,Notice of Final Determination from U.S. Patent and Trademark Office to Novo Nordisk Inc.,Other,Letter(s),2009-02-04T05:00:00Z,2009,2,2009-02-04T05:00:00Z,,2026-01-08T01:26:35Z,,0,0,0900006480838fa3
FDA-2006-E-0439-0009,FDA,FDA-2006-E-0439,Certificate Extending Patent Term from U.S. Patent and Trademark Office to Novo Nordisk Inc.,Other,Certificate Extending Patent Term,2008-11-05T05:00:00Z,2008,11,2008-11-05T05:00:00Z,,2026-01-08T01:20:40Z,,0,0,09000064806acad6
FDA-2006-E-0439-0008,FDA,FDA-2006-E-0439,Application for Patent Term Extension from Novo Nordisk Inc.,Other,Application,2008-11-05T05:00:00Z,2008,11,2008-11-05T05:00:00Z,,2026-01-08T01:18:25Z,,0,0,0900006480461eba
FDA-2006-E-0439-0007,FDA,FDA-2006-E-0439,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2007-10-24T04:00:00Z,2007,10,,,2026-01-08T01:15:09Z,,0,0,0900006480461ec7
FDA-2006-E-0439-0006,FDA,FDA-2006-E-0439,Determination of Regulatory Review Period for Purposes of Patent Extension; NOVOLOG,Notice,General Notice,2007-03-26T04:00:00Z,2007,3,2007-03-26T04:00:00Z,,2026-01-08T01:13:19Z,E7-5445,0,0,0900006480461ec5
FDA-2006-E-0439-0005,FDA,FDA-2006-E-0439,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2007-03-13T04:00:00Z,2007,3,,,2026-01-08T01:08:45Z,,0,0,0900006480461ec3
FDA-2006-E-0439-0004,FDA,FDA-2006-E-0439,Letter from U.S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2007-01-25T05:00:00Z,2007,1,,,2026-01-08T00:53:42Z,,0,0,0900006480461ec2
FDA-2006-E-0439-0003,FDA,FDA-2006-E-0439,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2006-12-12T05:00:00Z,2006,12,,,2026-01-08T00:50:31Z,,0,0,0900006480461ec1
FDA-2006-E-0439-0001,FDA,FDA-2006-E-0439,Letter from U.S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2006-11-29T05:00:00Z,2006,11,,,2026-01-08T00:43:18Z,,0,0,0900006480461ea5
FDA-2006-E-0439-0002,FDA,FDA-2006-E-0439,Notice Regarding Associate Power of Attorney from U.S. Patent and Trademark Office to Novo Nordisk Inc.,Other,Letter(s),2006-11-29T05:00:00Z,2006,11,,,2026-01-08T00:46:32Z,,0,0,0900006480461ebf